CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia

Li, Shuang; Zhao, Guangjie; Wu, Wanling; Li, Nianyi; Wang, Qian; Wang, Wei; Song, Xianmin; Wang, Xiaoqin

doi:10.1007/s10238-023-01243-6

Clin Exp Med

2023

DOI: 10.1007/s10238-023-01243-6

|View full text |Cite

CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia

Shuang Li,

Guangjie Zhao,

Wanling Wu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review

Gao,

Fan,

et al. 2024

Technol Cancer Res Treat

View full text Add to dashboard Cite

Objectives: While various serum and tissue biomarkers have been explored for tumor diagnosis, the sensitivity and specificity have not yield optimal results. Circular RNAs (circRNAs) are more stable, conserved, and tissue-specific than linear RNA. Recent reports indicate that circRNAs could serve as potential biomarkers in the diagnosis or/and prognosis of tumors. In this study, we systematically examined the relationship between circRNA expression and diagnostic and prognostic outcomes in patients with hematological tumors. Methods: We searched several databases, including Google Scholar, MEDLINE, Scopus, PubMed, Embase, ScienceDirect, Ovid-Medline, Chinese National Knowledge Infrastructure, WanFang and SinoMed, with a cutoff date of June 12, 2024. The study protocol was PROSPERO (CRD42020188627). Result: A total of 73 studies were included in our review, comprising 39 diagnostic studies and 65 prognostic studies. Clinical parameters were assessed based on pooled adds ratios and 95% confidence intervals (CIs). Overall survival (OS) was evaluated using hazard ratios (HRs) and 95% CIs. The pooled area under the curve was 0.86, indicating the potential to identify hematological tumor patients, with sensitivity and specificity of 79% each. The diagnostic score for circRNAs related to hematological malignancies was 2.12. Notably, different hematological malignancies subgroups displayed varying prognoses. Specifically, lymphoid leukemia circRNA showed a negative impacct on prognosis (HR = 1.25, 95% CI: 1.10-1.43, P < 0.001). Conclusion: Our findings provide compelling evidence that circRNA may be serve as a promising alternative for the diagnosis and prognosis of hematological tumors.

show abstract

Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review

Gao,

Fan,

et al. 2024

Technol Cancer Res Treat

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia

Cited by 1 publication

References 44 publications

Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review

Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review

Contact Info

Product

Resources

About